CNBX PHARMACEUTICALS INC. — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/16b69532-bf0d-444a-af91-602103769f17/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-271.7k | 2024-09-01 – 2025-08-31 | evidence 0001683168-25-008736 |
| FY 2024 | $-583.1k | 2023-09-01 – 2024-08-31 | evidence 0001683168-24-008433 |
| FY 2023 | $-931.4k | 2022-09-01 – 2023-08-31 | evidence 0001683168-23-008557 |
| FY 2022 | $-3.0M | 2021-09-01 – 2022-08-31 | evidence 0001683168-22-008095 |
| FY 2021 | $-2.6M | 2020-09-01 – 2021-08-31 | evidence 0001683168-21-006005 |
| FY 2020 | $-3.0M | 2019-09-01 – 2020-08-31 | evidence 0001683168-20-003686 |
| FY 2019 | $-3.3M | 2018-09-01 – 2019-08-31 | evidence 0001683168-19-003852 |
| FY 2018 | $-3.8M | 2017-09-01 – 2018-08-31 | evidence 0001683168-18-003584 |
| FY 2017 | $-1.9M | 2016-09-01 – 2017-08-31 | evidence 0001683168-17-003260 |
| FY 2016 | $-280.7k | 2015-09-01 – 2016-08-31 | evidence 0001683168-16-000925 |
| FY 2015 | $-536.5k | 2014-09-01 – 2015-08-31 | evidence 0001683168-16-000925 |
| FY 2014 | $-216.1k | 2013-09-01 – 2014-08-31 | evidence 0001019687-14-004710 |
| FY 2013 | $-601.1k | 2004-09-15 – 2014-05-31 | evidence 0001019687-14-002718 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CNBX PHARMACEUTICALS INC. — all facts · Revenue · Net Income